← Browse by Condition
Medical Condition
breast neoplasms
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for breast neoplasms sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — breast neoplasms Clinical Trials
How many clinical trials are currently recruiting for breast neoplasms?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for breast neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for breast neoplasms?
breast neoplasms research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a breast neoplasms clinical trial?
Eligibility criteria for breast neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06938373
Recruiting
Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression
Enrollment
1,000 pts
Location
China
Sponsor
Xiangya Hospital of Central So...
NCT06069115
Recruiting
Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort
Enrollment
200 pts
Location
Russia
Sponsor
Meshalkin Research Institute o...
NCT06421285
Recruiting
Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
Enrollment
60 pts
Location
South Korea
Sponsor
Asan Medical Center
NCT05607004 Phase 2
Recruiting
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Enrollment
87 pts
Location
United States
Sponsor
Atossa Therapeutics, Inc.
NCT07465393
Recruiting
Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors
Enrollment
66 pts
Location
Taiwan
Sponsor
Valeria Chiu
NCT01042379 Phase 2
Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Enrollment
5,000 pts
Location
United States
Sponsor
QuantumLeap Healthcare Collabo...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology